| Nanoparticles as a carrier system for drug delivery across blood brain barrier A Sarkar, I Fatima, Q Mohammad Sajid Jamal, U Sayeed, KA Khan, ... Current drug metabolism 18 (2), 129-137, 2017 | 39 | 2017 |
| Is gut dysbiosis an epicenter of Parkinson’s disease? C Rajput, A Sarkar, N Sachan, N Rawat, MP Singh Neurochemical research 46, 425-438, 2021 | 12 | 2021 |
| Involvement of peroxiredoxin-3, thioredoxin-2, and protein deglycase-1 in cypermethrin-induced Parkinsonism C Rajput, A Sarkar, MP Singh Molecular Neurobiology 58 (9), 4745-4757, 2021 | 11 | 2021 |
| Type 2 diabetes mellitus augments Parkinson’s disease risk or the other way around: facts, challenges and future possibilities M Faizan, A Sarkar, MP Singh Ageing Research Reviews 81, 101727, 2022 | 10 | 2022 |
| Unequivocal biomarker for Parkinson’s disease: a hunt that remains a pester A Sarkar, N Rawat, N Sachan, MP Singh Neurotoxicity Research 36, 627-644, 2019 | 9 | 2019 |
| Redox modulation of mitochondrial proteins in the neurotoxicant models of Parkinson's disease A Sarkar, MSU Rasheed, MP Singh Antioxidants & Redox Signaling 38 (10-12), 824-852, 2023 | 5 | 2023 |
| A complex interplay of DJ-1, LRRK2, and Nrf2 in the regulation of mitochondrial function in cypermethrin-induced parkinsonism A Sarkar, MP Singh Molecular Neurobiology 61 (2), 953-970, 2024 | 1 | 2024 |
| Cerebrospinal fluid protein biomarkers in Parkinson's disease M Faizan, N Sachan, O Verma, A Sarkar, N Rawat, MP Singh Clinica Chimica Acta, 117848, 2024 | | 2024 |
| Activation of DJ-1/Nrf2 signaling pathway ameliorates cypermethrin-induced oxidative damage in SH-SY5Y cells A Sarkar, MP Singh JOURNAL OF NEUROCHEMISTRY 162, 155-155, 2022 | | 2022 |
